Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 1, 2011, Pages 55-60

  Monzani, Alice ^a   Rapa, Anna ^a   Fonio, Paola ^b   Tognato, Eleonora ^a   Panigati, Laura ^a   Oderda, Giuseppina ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

anti gliadin; anti tissue transglutaminase; celiac disease; gluten free diet

Indexed keywords

GLIADIN ANTIBODY; IMMUNOGLOBULIN A; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIET THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GLUTEN FREE DIET; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROLOGY;

ADOLESCENT; ANTIBODIES; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIET, GLUTEN-FREE; GLIADIN; GLUTENS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; PATIENT COMPLIANCE; PEPTIDE FRAGMENTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TRANSGLUTAMINASES;

EID: 79959853981     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182145511     Document Type: Article

References (33)

1. Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357:1731-43.
2. Hill ID. What are the sensitivity and specificity of serologic tests for celiac disease? Gastroenterology 2005;128:S25-32.
3. Rostom A, Dube C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005;128:S38-46. (Pubitemid 40460820)
4. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801. (Pubitemid 27298728)
5. Collin P, Kaukinen K, Vogelsang H, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of celiac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol 2005;17:85-91. (Pubitemid 40136613)
6. Vahedi K, Mascart F, Mary JY, et al. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease. Am J Gastroenterol 2003;98:1079-87. (Pubitemid 36733770)
7. Kaukinen K, Sulkanen S, Maki M, et al. IgA class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in celiac disease. Eur J Gastroenterol Hepatol 2002;14:311-5. (Pubitemid 34259282)
8. Fabiani E, Catassi C, InternationalWorking Group. The serum IgA class anti-tissue transglutaminase antibodies in the diagnosis and follow up of coeliac disease. Results of an international multi-centre study. International Working Group on Eu-anti-tTG. Eur J Gastroenterol Hepatol 2001;13:659-65. (Pubitemid 32547864)
9. Molberg O, McAdam SN, Korner R. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998;14:713-7.
10. van de Wal Y, Kooy Y, Van Veelen P, et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 1998;161:1585-8. (Pubitemid 28387571)
11. Aleanzi M, Demonte AM, Esper C, et al. Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides. Clin Chem 2001;47:2023-8. (Pubitemid 33010719)
12. Osman AA, Gunnel T, Dietl A, et al. B cell epitopes of gliadin. Clin Exp Immunol 2000;121:248-54. (Pubitemid 30659761)
13. Schwertz E, Kahlenberg F, Sack U, et al. Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease. Clin Chem 2004;50:2370-5. (Pubitemid 39552174)
14. Dieterich W, Esslinger B, Trapp D, et al. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease. Gut 2006;55:478-84.
15. Kaukinen K, Collin P, Laurila K, et al. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol 2007;42: 1428-33. (Pubitemid 350125555)
16. Tonutti E, Visentini D, Picierno A, et al. Diagnostic efficacy of the ELISA test for the detection of deaminated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease. J Clin Lab Anal 2009;23:165-71.
17. Volta U, Granito A, Fiorini E, et al. Usefulness of antibodies to deaminated gliadin peptides in celiac disease diagnosis and followup. Dig Dis Sci 2008;53:1582-8.
18. Rashtak S, EttoreMW, Homburger HA, et al. Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol 2008;6:426-32.
19. Liu E, Li M, Emery L, et al. Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease. J Pediatr Gastroenterol Nutr 2007;45:293-300. (Pubitemid 47415079)
20. Basso D, Guariso G, Fogar P, et al. Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and followup in children. Clin Chem 2009;55:150-7.
21. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (celiac sprue'). Gastroenterology 1992;102:330-54.
22. Prause C, Ritter M, Probst C, et al. Antibodies against deamidated gliadin as new and accurate biomarkers of childhood coeliac disease. J Pediatr Gastroenterol Nutr 2009;49:52-8.
23. Vermeersch P, Geboes K, Marien̈ G, et al. Diagnostic performance of IgG anti-deamidated gliadin peptide antibody assays is comparable to IgA anti-tTG in celiac disease. Clin Chim Acta 2010;411:931-5.
24. Jaskowski TD, Donaldson MR, Hull CM, et al. Novel screening assay performance in pediatric celiac disease and adult dermatitis herpetiformis. J Pediatr Gastroenterol Nutr 2010;51:19-23.
25. Agardh D. Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease. Clin Gastroenterol Hepatol 2007;5:1276-81. (Pubitemid 350019051)
26. Hogen Esch CE, Csizmadia GD, van Hoogstraten IM, et al. Childhood coeliac disease: towards an improved serological mass screening strategy. Aliment Pharmacol Ther 2010;31:760-6.
27. Lewis NR, Scott BB. Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease. Aliment Pharmacol Ther 2010;31:73-81.
28. Leffler DA, Edwards George JB, Dennis M, et al. A prospective comparative study of five measures of gluten-free diet adherence in adults with coeliac disease. Aliment Pharmacol Ther 2007;26:1227-35. (Pubitemid 47620424)
29. Sugai E, Nachman F, Váquez H, et al. Dynamics of celiac diseasespecific serology after initiation of a gluten-free diet and use in the assessment of compliance with treatment. Dig Liver Dis 2010; 42:352-8.
30. Holmes GK, Prior P, Lane MR, et al. Malignancy in coeliac disease: effect of a gluten free diet. Gut 1989;30:333-8. (Pubitemid 19091159)
31. Kolsteren MM, Koopman HM, Schalekamp G, et al. Health related quality of life in children with celiac disease. J Pediatr 2001;138:593-5. (Pubitemid 32319739)
32. Wagner G, Berger G, Sinnreich U, et al. Quality of life in adolescents with treated coeliac disease: influence of compliance and age at diagnosis. J Pediatr Gastroenterol Nutr 2008;47:555-61.
33. Nachman F, Del Campo MP, González A, et al. Long-term deterioration of quality of life in adult patients with celiac disease is associated with treatment noncompliance. Dig Liv Dis 2010;42:685-91.